Amazon.com, Cleveland-Cliffs, Disc Medicine, Silence Therapeutics and EyePoint: Why These 5 Stocks Are on Investors' Radars Today
Major U.S. indices ended mixed on Monday, with the Dow Jones Industrial Average slipping 0.07% to 51,966.03.
Stocks · News reference
Market sentiment improved slightly but stayed in extreme fear. Nasdaq rose 1.11%, while Silence Therapeutics surged 126% on Merck deal.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Major U.S. indices ended mixed on Monday, with the Dow Jones Industrial Average slipping 0.07% to 51,966.03.
Cleveland-Cliffs reported Q3 2026 adjusted EBITDA more than doubled to $612 million, driven by domestic trade protections and strong steel pricing. The company secured multiyear supply contracts expected to generate $1 billion in incremental EBITDA, postponed a furnace maintenance outage to preserve 500,000 tons of production, and committed all free cash flow to debt reduction. Management projects over $4 billion in EBITDA for 2027 under similar market conditions.
Cleveland-Cliffs stock surged 16.34% after reporting stronger Q3 results with adjusted EBITDA more than doubling to $612 million and raising its 2027 EBITDA outlook to exceed $4 billion. The strong performance boosted other domestic steel stocks, though Steel Dynamics fell after earnings missed estimates despite record shipments.
GE Aero (NYSE:GE) reported quarterly earnings of $2.25 per share which beat the analyst consensus estimate of $2.00 by 12.5 percent. This is a 35.54 percent increase over earnings of $1.66 per share from the same period
U.S. stock futures were swinging between gains and losses on Tuesday, as Dow Jones rose, while the S&P 500 and the Nasdaq 100 indices fell.
GM and GE report earnings Tuesday; Steel Dynamics missed estimates. SpaceX and Netflix are due after the close.